Condition: Burns · Sponsor: Skingenix, Inc.
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
This description comes directly from the study's public registry record.
Vicki Christodoulou, MS, JD · 909-587-1650 · vickic@skingenixusa.com
Eric Wang, MD · 909-587-1650 · ericw@skingenixusa.com
Always discuss trial participation with your own doctor first.
| Valleywise Health Medical Center | Phoenix, Arizona, United States | Recruiting |
| University of CA Davis Medical Center | Sacramento, California, United States | Recruiting |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| University of Iowa Health Care | Iowa City, Iowa, United States | Recruiting |
| Proactive CR Mexico SA de CV | Irapuato, Mexico | Recruiting |
| SMIQ S de R. L de CV | Querétaro City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01297400